Less Ads, More Data, More Tools Register for FREE

Friday broker round-up - UPDATE

Fri, 03rd Feb 2012 09:09
Royal Bank of Scotland: Deutsche Bank downgrades to hold from buy.BT Group: Nomura reiterates buy recommendation and 285p target.AstraZeneca: Nomura keeps reduce rating and 2,400p target.GlaxoSmithKline: Nomura reiterates neutral rating and 1,220p target.Royal Dutch Shell B: Nomura raises target from 2,700p to 2,800p, buy rating kept.Misys: Merchant Securities confirms sell rating and 220p target.QinetiQ: UBS raises target from 135p to 145p, neutral rating unchanged.Electrocomponents: Peel Hunt reiterates sell rating and 180p target.Fuller Smith & Turner: Peel Hunt keeps buy recommendation and 790p target.Game Group: Peel Hunt maintains hold and 5p target.Porvair: Peel Hunt keeps buy rating and 122p target. Astrazeneca Fuller Smith & Turner Qinetiq Glaxosmithkline BT

Shares in this article

Related News

GSK posts encouraging data for bowel cancer treatment Jemperli
1 hour ago

GSK posts encouraging data for bowel cancer treatment Jemperli

(Alliance News) - GSK PLC on Monday reported encouraging trial data for its cancer treatment Jemperli, also known as dostarlimab.

LONDON BROKER RATINGS: HSBC cuts Astra; Stifel raises Computacenter
1 hour ago

LONDON BROKER RATINGS: HSBC cuts Astra; Stifel raises Computacenter

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday:

LONDON MARKET OPEN: Oil gains lift BP as Iran tensions weigh
1 hour ago

LONDON MARKET OPEN: Oil gains lift BP as Iran tensions weigh

(Alliance News) - Stock prices in London opened slightly lower on Monday as renewed tensions between the US and Iran lifted oil prices.

Commodities Persimmon + 10 more shares